Immunological capabilities of skeletal muscle cells

被引:47
作者
Nagaraju, K [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 2001年 / 171卷 / 03期
关键词
adhesion molecules and cytokines; antigen presenting cells; co-stimulatory molecules; Fas; immune response; major histocompatibility complex; skeletal muscle cells;
D O I
10.1046/j.1365-201x.2001.00823.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Muscle is the target of immunological injury in several muscle diseases. It is important therefore to understand the immunological capabilities of muscle cells themselves. Although it is conventional to discuss the effects of the immune system on other cells, tissues or organs, the system's boundaries cannot be sharply drawn, and in an increasing number of ways, the immunological capabilities of non-immune tissues are recognized as determining the course of immune-inflammatory processes. Muscle cells have an inherent ability to express and respond to a variety of immunologically relevant surface molecules, cytokines, and chemokines under inflammatory conditions. The ability of muscle cells to process and present antigens to the immune cells is currently debated; thus, this review is aimed at examining the immunological capabilities of skeletal muscle cells in vitro and in vivo.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 75 条
[41]   Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies [J].
Liprandi, A ;
Bartoli, C ;
Figarella-Branger, D ;
Pellissier, JF ;
Lepidi, H .
ACTA NEUROPATHOLOGICA, 1999, 97 (06) :642-648
[42]  
Liprandi A, 1999, ANN PATHOL, V19, P12
[43]   Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies [J].
Lundberg, I ;
Ulfgren, AK ;
Nyberg, P ;
Andersson, U ;
Klareskog, L .
ARTHRITIS AND RHEUMATISM, 1997, 40 (05) :865-874
[44]  
Lundberg Ingrid E., 1998, Current Opinion in Rheumatology, V10, P521, DOI 10.1097/00002281-199811000-00004
[45]   Major histocompatibility complex class II molecule expression on muscle cells is regulated by differentiation: Implications for the immunopathogenesis of muscle autoimmune diseases [J].
Mantegazza, R ;
Gebbia, M ;
Mora, M ;
Barresi, R ;
Bernasconi, P ;
Baggi, F ;
Cornelio, F .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) :53-60
[46]   MODULATION OF MHC CLASS-II ANTIGEN EXPRESSION IN HUMAN MYOBLASTS AFTER TREATMENT WITH IFN-GAMMA [J].
MANTEGAZZA, R ;
HUGHES, SM ;
MITCHELL, D ;
TRAVIS, M ;
BLAU, HM ;
STEINMAN, L .
NEUROLOGY, 1991, 41 (07) :1128-1132
[47]   Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells [J].
MarelliBerg, FM ;
Hargreaves, REG ;
Carmichael, P ;
Dorling, A ;
Lombardi, G ;
Lechler, RI .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1603-1612
[48]   EXPRESSION OF CLASS-I AND CLASS-II MHC ANTIGENS IN NEUROMUSCULAR DISEASES [J].
MCDOUALL, RM ;
DUNN, MJ ;
DUBOWITZ, V .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 89 (2-3) :213-226
[49]  
MICHAELIS D, 1993, AM J PATHOL, V143, P1142
[50]   CELL TRANSPLANTATION AND GENE-THERAPY IN MUSCULAR-DYSTROPHY [J].
MORGAN, JE ;
PARTRIDGE, TA .
BIOESSAYS, 1992, 14 (09) :641-645